1. Home
  2. AHT vs CLGN Comparison

AHT vs CLGN Comparison

Compare AHT & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AHT

Ashford Hospitality Trust Inc

HOLD

Current Price

$3.18

Market Cap

18.1M

Sector

Real Estate

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.37

Market Cap

18.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHT
CLGN
Founded
2003
2004
Country
United States
Israel
Employees
116
N/A
Industry
Real Estate Investment Trusts
Industrial Specialties
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
18.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
AHT
CLGN
Price
$3.18
$0.37
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
25.1K
128.3K
Earning Date
05-05-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.36
$240.45
Revenue Next Year
N/A
$38.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$0.27
52 Week High
$7.55
$4.98

Technical Indicators

Market Signals
Indicator
AHT
CLGN
Relative Strength Index (RSI) 63.96 36.00
Support Level $2.90 N/A
Resistance Level $3.26 $0.73
Average True Range (ATR) 0.14 0.08
MACD 0.07 0.00
Stochastic Oscillator 98.56 28.75

Price Performance

Historical Comparison
AHT
CLGN

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc is a real estate investment trust (REIT) operating in the hotel lodging industry. The company's portfolio consists of upscale and upper upscale full-service hotels, with its investment focused on acquiring and investing in upper upscale full-service hotels in the United States that have revenue per available room (RevPAR) generally less than twice the U.S. national average, through direct real estate ownership as well as equity and debt investments. Its hotel properties are mainly branded under internationally recognized names such as Hilton, Hyatt, Marriott, and InterContinental Hotels Group. It operates through a single reportable business segment, direct hotel investments, which involves owning hotel properties through acquisitions or new development.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: